---
title: "MicuRx shareholders plan to reduce their holdings by no more than 6%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256570403.md"
description: "According to the Zhitong Finance APP, MicuRx announced that the company recently received a notice regarding the shareholder reduction plan from Best Idea, JSR, and GP TMT. Shareholders Best Idea, JSR, and GPTMT plan to reduce their holdings of the company's shares by no more than 39.3363 million shares, which is no more than 6% of the company's total share capital, depending on market conditions through centralized bidding and block trading"
datetime: "2025-09-09T12:45:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256570403.md)
  - [en](https://longbridge.com/en/news/256570403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256570403.md)
generator: "portal-rs"
---

# MicuRx shareholders plan to reduce their holdings by no more than 6%

According to the announcement from Zhitong Finance APP, MicuRx (688373.SH) recently received a notice regarding the shareholder reduction plan from Best Idea, JSR, and GP TMT. Shareholders Best Idea, JSR, and GPTMT plan to reduce their holdings of the company's shares by no more than 39.3363 million shares, which is no more than 6% of the company's total share capital, depending on market conditions through centralized bidding and block trading

### Related Stocks

- [688373.CN](https://longbridge.com/en/quote/688373.CN.md)

## Related News & Research

- [Sugar Prices Consolidate Below Last Week’s Significant Highs](https://longbridge.com/en/news/296819776.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**